Predict value of peripheral blood eosinophilia in acute exacerbation of chronic obstructive pulmonary disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024210

Enrollment

Unknown

Registered

2019-06-30

Start date

2019-07-31

Completion date

Unknown

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Grouped by level of EOS:None

Eligibility

Sex/Gender

All

Age

40 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients of age 40 years or more with AECOPD emergency treatment or hospitalization; 2. Obtaining peripheral blood routine for the first time before receive system hormone therapy (prednisone > 0.5 mg/kg) or equivalent hormone.

Exclusion criteria

Exclusion criteria: 1. The main therapeutic purpose has nothing to do with AECOPD; 2. Previous diagnosed of asthma or asthma - copd overlap; 3. There are other diseases inducing rise and fall of eosinophils (allergic diseases, parasitic infections, eosinophils pneumonia, etc.) or state; 4. There are other organs or systems of severe dysfunction or malignant tumor.

Design outcomes

Primary

Measure	Time frame
stay of hospital;Noninvasive ventilation rate;Duration of noninvasive ventilation;comorbidity;	—

Countries

China

Contacts

Public ContactDeyun Cheng

West China Hospital

chengdeyunscu@163.com+86 18980601260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026